Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Medtronic might acquire LivaNova’s neuromodulation business


Is Medtron­ic eye­ing LivaNo­va for a takeover? (MASS Device):

Some indus­try ana­lysts are spec­u­lat­ing that Medtron­ic (NYSE:MDT) might want to acquire LivaNo­va (NSDQ:LIVN) for its neu­ro­mod­u­la­tion busi­ness … “While we think that this deal could make sense since it would bol­ster MDT’s neu­ro­mod­u­la­tion busi­ness and since we believe that LIVN is under­val­ued par­tic­u­lar­ly con­sid­er­ing its pipeline, we think it is far from a cer­tain­ty,” Need­ham & Co. ana­lyst Mike Mat­son wrote sep­a­rate­ly on Fri­day.

We think the deal as described above would be pos­i­tive for MDT,” Mat­son wrote. “MDT is the mar­ket leader in neu­ro­mod­u­la­tion and we esti­mate that its neu­ro­mod­u­la­tion mar­ket share is 43%. MDT offers spinal cord stim­u­la­tion (SCS), deep brain stim­u­la­tion (DBS), and sacral neu­ro­mod­u­la­tion (SNM) prod­ucts but does not offer vagal nerve stim­u­la­tion (VNS). In con­trast, LIVN is the mar­ket leader in VNS and we esti­mate that its neu­ro­mod­u­la­tion mar­ket share is 9%. Giv­en this, we believe that VNS would be com­ple­men­tary to MDT’s cur­rent neu­ro­mod­u­la­tion busi­ness.”

News in Context:

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness, Technology

Tags: , , , , , ,

Search in our Archives

Follow us and Engage via…

RSS Feed

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Watch All Recordings Now (40+ Speakers, 12+ Hours)